The information presented in this study display that the PEPCK pathway, classically regarded as as the rate-limiting phase of the de novo hepatic glucose manufacturing, is decreased in the liver of the FynKO mice
FynKO mice also had lowered glucose excursion in the course of glucose tolerance checks...